Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement Relates to the submission of a marketing approval application in JapanMarks strong progress in 2016 agreement and further boosts Mithra’s cash positionAdditional EUR 10 million in milestone payments expected at approval of marketing authorizationMithra eligible for revenue from supply of the manufactured product post-commercialization Liege, Belgium, 23 October 2023 – 07:00 CEST – Mithra (Euro